Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand

Kathleen M. MacQueen, Suphak Vanichseni, Dwip Kitayaporn, Lillian S. Lin, Aumphornpun Buavirat, Thananda Naiwatanakul, Suwanee Raktham, Philip Mock, William L. Heyward, Don Des Jarlais, Kachit Choopanya, Timothy D. Mastro

Research output: Contribution to journalArticle

Abstract

We assessed willingness to participate in an HIV recombinant gp120 bivalent subtypes B/E candidate vaccine efficacy trial among 193 injection drag users (IDUs) attending drag treatment clinics in Bangkok, Thailand. IDUs previously enrolled in a prospective cohort study were invited to group sessions describing a potential trial, then completed questionnaires assessing comprehension and willingness to participate. A week later, they completed a follow-up questionnaire that again assessed comprehension and willingness to participate, as well as barriers to and positive motives for participation, with whom (if anyone) they talked about the information, and whether others thought participation was a good, bad, or neutral idea. At baseline, 51% were definitely willing to participate, and at follow-up 54%; only 3% were not willing to participate at either time. Comprehension was high at baseline and improved at follow-up. Participants who viewed altruism, regular HIV tests, and family support for participation as important were more willing to volunteer. Frequency of incarceration and concerns about the length of the trial, possible vaccine-induced accelerated disease progression, and lack of family support were negatively associated with willingness. Overall, IDUs comprehended the information needed to make a fully informed decision about participating in an rgp120 vaccine efficacy trial and expressed a high level of willingness to participate in such a trial.

Original languageEnglish (US)
Pages (from-to)243-251
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume21
Issue number3
StatePublished - Jul 1 1999

Fingerprint

AIDS Vaccines
Thailand
Drug Users
Vaccines
Injections
HIV Envelope Protein gp120
Altruism
Disease Progression
Volunteers
Cohort Studies
HIV
Prospective Studies
Surveys and Questionnaires
Therapeutics

Keywords

  • Attitudes
  • Drug users
  • HIV-1
  • Knowledge
  • Thailand
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Virology

Cite this

MacQueen, K. M., Vanichseni, S., Kitayaporn, D., Lin, L. S., Buavirat, A., Naiwatanakul, T., ... Mastro, T. D. (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 21(3), 243-251.

Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. / MacQueen, Kathleen M.; Vanichseni, Suphak; Kitayaporn, Dwip; Lin, Lillian S.; Buavirat, Aumphornpun; Naiwatanakul, Thananda; Raktham, Suwanee; Mock, Philip; Heyward, William L.; Des Jarlais, Don; Choopanya, Kachit; Mastro, Timothy D.

In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 21, No. 3, 01.07.1999, p. 243-251.

Research output: Contribution to journalArticle

MacQueen, KM, Vanichseni, S, Kitayaporn, D, Lin, LS, Buavirat, A, Naiwatanakul, T, Raktham, S, Mock, P, Heyward, WL, Des Jarlais, D, Choopanya, K & Mastro, TD 1999, 'Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand', Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 21, no. 3, pp. 243-251.
MacQueen, Kathleen M. ; Vanichseni, Suphak ; Kitayaporn, Dwip ; Lin, Lillian S. ; Buavirat, Aumphornpun ; Naiwatanakul, Thananda ; Raktham, Suwanee ; Mock, Philip ; Heyward, William L. ; Des Jarlais, Don ; Choopanya, Kachit ; Mastro, Timothy D. / Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1999 ; Vol. 21, No. 3. pp. 243-251.
@article{944c70a91f3149e2809e0ddf588cd76e,
title = "Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand",
abstract = "We assessed willingness to participate in an HIV recombinant gp120 bivalent subtypes B/E candidate vaccine efficacy trial among 193 injection drag users (IDUs) attending drag treatment clinics in Bangkok, Thailand. IDUs previously enrolled in a prospective cohort study were invited to group sessions describing a potential trial, then completed questionnaires assessing comprehension and willingness to participate. A week later, they completed a follow-up questionnaire that again assessed comprehension and willingness to participate, as well as barriers to and positive motives for participation, with whom (if anyone) they talked about the information, and whether others thought participation was a good, bad, or neutral idea. At baseline, 51{\%} were definitely willing to participate, and at follow-up 54{\%}; only 3{\%} were not willing to participate at either time. Comprehension was high at baseline and improved at follow-up. Participants who viewed altruism, regular HIV tests, and family support for participation as important were more willing to volunteer. Frequency of incarceration and concerns about the length of the trial, possible vaccine-induced accelerated disease progression, and lack of family support were negatively associated with willingness. Overall, IDUs comprehended the information needed to make a fully informed decision about participating in an rgp120 vaccine efficacy trial and expressed a high level of willingness to participate in such a trial.",
keywords = "Attitudes, Drug users, HIV-1, Knowledge, Thailand, Vaccine",
author = "MacQueen, {Kathleen M.} and Suphak Vanichseni and Dwip Kitayaporn and Lin, {Lillian S.} and Aumphornpun Buavirat and Thananda Naiwatanakul and Suwanee Raktham and Philip Mock and Heyward, {William L.} and {Des Jarlais}, Don and Kachit Choopanya and Mastro, {Timothy D.}",
year = "1999",
month = "7",
day = "1",
language = "English (US)",
volume = "21",
pages = "243--251",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand

AU - MacQueen, Kathleen M.

AU - Vanichseni, Suphak

AU - Kitayaporn, Dwip

AU - Lin, Lillian S.

AU - Buavirat, Aumphornpun

AU - Naiwatanakul, Thananda

AU - Raktham, Suwanee

AU - Mock, Philip

AU - Heyward, William L.

AU - Des Jarlais, Don

AU - Choopanya, Kachit

AU - Mastro, Timothy D.

PY - 1999/7/1

Y1 - 1999/7/1

N2 - We assessed willingness to participate in an HIV recombinant gp120 bivalent subtypes B/E candidate vaccine efficacy trial among 193 injection drag users (IDUs) attending drag treatment clinics in Bangkok, Thailand. IDUs previously enrolled in a prospective cohort study were invited to group sessions describing a potential trial, then completed questionnaires assessing comprehension and willingness to participate. A week later, they completed a follow-up questionnaire that again assessed comprehension and willingness to participate, as well as barriers to and positive motives for participation, with whom (if anyone) they talked about the information, and whether others thought participation was a good, bad, or neutral idea. At baseline, 51% were definitely willing to participate, and at follow-up 54%; only 3% were not willing to participate at either time. Comprehension was high at baseline and improved at follow-up. Participants who viewed altruism, regular HIV tests, and family support for participation as important were more willing to volunteer. Frequency of incarceration and concerns about the length of the trial, possible vaccine-induced accelerated disease progression, and lack of family support were negatively associated with willingness. Overall, IDUs comprehended the information needed to make a fully informed decision about participating in an rgp120 vaccine efficacy trial and expressed a high level of willingness to participate in such a trial.

AB - We assessed willingness to participate in an HIV recombinant gp120 bivalent subtypes B/E candidate vaccine efficacy trial among 193 injection drag users (IDUs) attending drag treatment clinics in Bangkok, Thailand. IDUs previously enrolled in a prospective cohort study were invited to group sessions describing a potential trial, then completed questionnaires assessing comprehension and willingness to participate. A week later, they completed a follow-up questionnaire that again assessed comprehension and willingness to participate, as well as barriers to and positive motives for participation, with whom (if anyone) they talked about the information, and whether others thought participation was a good, bad, or neutral idea. At baseline, 51% were definitely willing to participate, and at follow-up 54%; only 3% were not willing to participate at either time. Comprehension was high at baseline and improved at follow-up. Participants who viewed altruism, regular HIV tests, and family support for participation as important were more willing to volunteer. Frequency of incarceration and concerns about the length of the trial, possible vaccine-induced accelerated disease progression, and lack of family support were negatively associated with willingness. Overall, IDUs comprehended the information needed to make a fully informed decision about participating in an rgp120 vaccine efficacy trial and expressed a high level of willingness to participate in such a trial.

KW - Attitudes

KW - Drug users

KW - HIV-1

KW - Knowledge

KW - Thailand

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=0033166971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033166971&partnerID=8YFLogxK

M3 - Article

C2 - 10421249

AN - SCOPUS:0033166971

VL - 21

SP - 243

EP - 251

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -